Update in Nonpulmonary Critical Care Acquired Neuromuscular Disorders in the Intensive Care Unit
暂无分享,去创建一个
[1] J. Willeit,et al. Polyneuropathies in critically ill patients: A prospective evaluation , 1996, Intensive Care Medicine.
[2] V. P. Misra,et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness* , 2003, Critical care medicine.
[3] Arthur S Slutsky,et al. One-year outcomes in survivors of the acute respiratory distress syndrome. , 2003, The New England journal of medicine.
[4] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[5] Isabelle Durand-Zaleski,et al. Paresis acquired in the intensive care unit: a prospective multicenter study. , 2002, JAMA.
[6] H. Sander,et al. Quadriplegic areflexic ICU illness: Selective thick filament loss and normal nerve histology , 2002, Muscle & nerve.
[7] A. Aljada,et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. , 2002, The Journal of clinical endocrinology and metabolism.
[8] S. Nasraway,et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. , 2002, Critical care medicine.
[9] L. Visser,et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients , 2001, Critical care medicine.
[10] W. Trojaborg,et al. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy – a reappraisal , 2001, Clinical Neurophysiology.
[11] J. Garnacho-Montero,et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients , 2001, Intensive Care Medicine.
[12] D C Angus,et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.
[13] R. Roine,et al. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis , 2000, Intensive Care Medicine.
[14] J. Haas,et al. Incidence and onset of critical illness polyneuropathy in patients with septic shock. , 2000, Netherlands Journal of Medicine.
[15] S. Hagl,et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'. , 2000, The Thoracic and cardiovascular surgeon.
[16] U. Zifko. Long‐term outcome of critical illness polyneuropathy , 2000, Muscle & nerve. Supplement.
[17] G. Rubenfeld,et al. The effect of acute respiratory distress syndrome on long-term survival. , 1999, American journal of respiratory and critical care medicine.
[18] E. Hund. Myopathy in critically ill patients. , 1999, Critical care medicine.
[19] P. Paré,et al. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. , 1999, Chest.
[20] J. Lefaucheur,et al. Acquired neuromuscular disorders in critically ill patients: a systematic review , 1998, Intensive Care Medicine.
[21] A. Fowler,et al. Prolonged weakness after cisatracurium infusion: a case report. , 1998, Critical care medicine.
[22] M. Pinter,et al. Loss of electrical excitability in an animal model of acute quadriplegic myopathy , 1998, Annals of neurology.
[23] C. Strange,et al. Comparison of train-of-four and best clinical assessment during continuous paralysis. , 1997, American journal of respiratory and critical care medicine.
[24] N. Latronico,et al. Predominant involvement of motor fibres in patients with critical illness polyneuropathy. , 1997, British journal of anaesthesia.
[25] M. Rich,et al. Direct muscle stimulation in acute quadriplegic myopathy , 1997, Muscle & nerve.
[26] E Angus,et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. , 1997, Critical care medicine.
[27] M. Rudis,et al. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. , 1996, Critical care medicine.
[28] W S David,et al. Muscle weakness in mechanically ventilated patients with severe asthma. , 1996, American journal of respiratory and critical care medicine.
[29] M. Rich,et al. Muscle is electrically inexcitable in acute quadriplegic myopathy , 1996, Neurology.
[30] F. Leijten,et al. The Role of Polyneuropathy in Motor Convalescence After Prolonged Mechanical Ventilation , 1995 .
[31] D. Ishii,et al. Insulin‐like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats , 1995, Journal of neuroscience research.
[32] E. Wijdicks,et al. The clinical spectrum of critical illness polyneuropathy. , 1994, Mayo Clinic proceedings.
[33] R. Prielipp,et al. Prolonged weakness after infusion of atracurium in two intensive care unit patients. , 1994, Anesthesia and analgesia.
[34] Y. Kupfer,et al. Prolonged Weakness after Long-Term Infusion of Vecuronium Bromide , 1992, Annals of Internal Medicine.
[35] R D Miller,et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. , 1992, The New England journal of medicine.
[36] M. Weinmann,et al. Myopathy in severe asthma. , 1992, The American review of respiratory disease.
[37] G. Awerbuch,et al. NEUROMUSCULAR CAUSES OF VENTILATOR DEPENDENCY , 1992 .
[38] R. Griffiths,et al. Necrotizing myopathy in critically‐ill patients , 1991, The Journal of pathology.
[39] W. Sibbald,et al. Peripheral nerve function in sepsis and multiple organ failure. , 1991, Chest.
[40] B. Partridge,et al. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. , 1990, Critical care medicine.
[41] E. Zomer,et al. [Critical illness polyneuropathy]. , 1990, Nederlandsch tijdschrift voor geneeskunde.
[42] M. Horne,et al. Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. , 1988, The American review of respiratory disease.
[43] C. Bolton,et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.
[44] I. G. Marshall,et al. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. , 1983, British journal of anaesthesia.
[45] I. MacFarlane,et al. SEVERE MYOPATHY AFTER STATUS ASTHMATICUS , 1977, The Lancet.